Steven Barth Discusses Regulatory Hurdles for Strategic Buyers
October 15, 2024
S&P Global
Foley & Lardner LLP partner Steven Barth commented on the regulatory hurdles strategic buyers face in the S&P Global article, “Private equity fuels TMT M&A for 2nd consecutive quarter in Q3.”
“We live in a current regulatory environment where we can no longer provide reliable advance advice to our clients about whether a deal will likely receive regulatory approval,” Barth explained, highlighting that consequentially, transactional attorneys are emphasizing caution when advising clients.
“We like to be right. And on deals that never get submitted for approval, we’re always right,” Barth added.
Barth’s commentary also appeared in the S&P Global article, “Private equity deals regain momentum; buyout shops lead TMT sector M&A.”
People
Related News
April 3, 2026
In the News
David Rosen Weighs in on FDA's Pharma PR Crackdown – 'Stick to the Data'
Foley & Lardner LLP partner David Rosen shared insights on the regulatory challenges pharmaceutical companies face when publicly communicating around new cancer therapies in the MM+M article, “When a podcast becomes promotion: Inside the FDA’s warning shot at ImmunityBio.”
April 3, 2026
In the News
Jami Gekas Named to Law360’s 2026 Intellectual Property Editorial Advisory Board
Foley & Lardner LLP partner Jami Gekas has been named to Law360's 2026 Intellectual Property Editorial Advisory Board.
April 2, 2026
In the News
Susan Poll Klaessy and Adrienne Walker Named Chair and Vice Chair of Foley’s Bankruptcy & Business Reorganizations Practice
Foley & Lardner LLP partner Susan Poll Klaessy was appointed chair of the firm’s global Bankruptcy & Business Reorganizations Practice Group. Partner Adrienne Walker will serve as vice chair, supporting the continued growth and strategic direction of the practice.